175 related articles for article (PubMed ID: 30011114)
21. Manifesting heterozygotes in McArdle disease: a myth or a reality-role of statins.
Núñez-Manchón J; Ballester-Lopez A; Koehorst E; Linares-Pardo I; Coenen D; Ara I; Rodriguez-Lopez C; Ramos-Fransi A; Martínez-Piñeiro A; Lucente G; Almendrote M; Coll-Cantí J; Pintos-Morell G; Santos-Lozano A; Arenas J; Martín MA; de Castro M; Lucia A; Santalla A; Nogales-Gadea G
J Inherit Metab Dis; 2018 Nov; 41(6):1027-1035. PubMed ID: 29926259
[TBL] [Abstract][Full Text] [Related]
22. McArdle disease: molecular genetic update.
Andreu AL; Nogales-Gadea G; Cassandrini D; Arenas J; Bruno C
Acta Myol; 2007 Jul; 26(1):53-7. PubMed ID: 17915571
[TBL] [Abstract][Full Text] [Related]
23. Gene symbol: PYGM. Disease: McArdle disease.
Viéitez I; Teijeira S; Miranda S; San Millán B; Navarro C
Hum Genet; 2008 Oct; 124(3):294. PubMed ID: 18846609
[No Abstract] [Full Text] [Related]
24. Gene symbol: PYGM. Disease: McArdle disease.
Viéitez I; Teijeira S; San Millán B; Navarro C
Hum Genet; 2008 Oct; 124(3):320. PubMed ID: 18846677
[No Abstract] [Full Text] [Related]
25. Gene symbol: PYGM. Disease: McArdle disease.
Viéitez I; Teijeira S; San Millán B; Navarro C
Hum Genet; 2008 Oct; 124(3):307. PubMed ID: 18846642
[No Abstract] [Full Text] [Related]
26. Analysis of spectrum and frequencies of mutations in McArdle disease. Identification of 13 novel mutations.
Deschauer M; Morgenroth A; Joshi PR; Gläser D; Chinnery PF; Aasly J; Schreiber H; Knape M; Zierz S; Vorgerd M
J Neurol; 2007 Jun; 254(6):797-802. PubMed ID: 17404776
[TBL] [Abstract][Full Text] [Related]
27. The pathogenomics of McArdle disease--genes, enzymes, models, and therapeutic implications.
Nogales-Gadea G; Santalla A; Brull A; de Luna N; Lucia A; Pinós T
J Inherit Metab Dis; 2015 Mar; 38(2):221-30. PubMed ID: 25053163
[TBL] [Abstract][Full Text] [Related]
28. Six novel mutations in the myophosphorylase gene in patients with McArdle disease and a family with pseudo-dominant inheritance pattern.
Wu Y; Weber JL; Vladutiu GD; Tarnopolsky MA
Mol Genet Metab; 2011 Dec; 104(4):587-91. PubMed ID: 21880526
[TBL] [Abstract][Full Text] [Related]
29. Absence of p.R50X
Tarrasó G; Real-Martinez A; Parés M; Romero-Cortadellas L; Puigros L; Moya L; de Luna N; Brull A; Martín MA; Arenas J; Lucia A; Andreu AL; Barquinero J; Vissing J; Krag TO; Pinós T
Dis Model Mech; 2020 Jan; 13(1):. PubMed ID: 31848135
[TBL] [Abstract][Full Text] [Related]
30. The effect of muscle glycogen phosphorylase (Pygm) knockdown on zebrafish morphology.
Migocka-Patrzałek M; Lewicka A; Elias M; Daczewska M
Int J Biochem Cell Biol; 2020 Jan; 118():105658. PubMed ID: 31747538
[TBL] [Abstract][Full Text] [Related]
31. Sodium valproate increases the brain isoform of glycogen phosphorylase: looking for a compensation mechanism in McArdle disease using a mouse primary skeletal-muscle culture in vitro.
de Luna N; Brull A; Guiu JM; Lucia A; Martin MA; Arenas J; Martí R; Andreu AL; Pinós T
Dis Model Mech; 2015 May; 8(5):467-72. PubMed ID: 25762569
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis and genetic analysis of a case with glycogen storage disease type V caused by compound heterozygous mutations in the PYGM gene.
Jiang WZ; Xu YW; Wang YW; Zhu XC; Gong YY; Zhou HW; Fu ZZ
Yi Chuan; 2022 Nov; 44(11):1063-1071. PubMed ID: 36384998
[TBL] [Abstract][Full Text] [Related]
33. Whole-exome sequencing detects
Thomas-Wilson A; Dharmadhikari AV; Heymann JJ; Jobanputra V; DiMauro S; Hirano M; Naini AB; Ganapathi M
Cold Spring Harb Mol Case Stud; 2022 Feb; 8(2):. PubMed ID: 35022222
[TBL] [Abstract][Full Text] [Related]
34. Identification of a novel PYGM mutation in a McArdle disease patient misdiagnosed as hypokalemic periodic paralysis.
Xie RR; Yang YB; Jin P
J Endocrinol Invest; 2020 May; 43(5):697-698. PubMed ID: 32100198
[No Abstract] [Full Text] [Related]
35. High-resolution melting facilitates mutation screening of PYGM in patients with McArdle disease.
Duno M; Quinlivan R; Vissing J; Schwartz M
Ann Hum Genet; 2009 May; 73(Pt 3):292-7. PubMed ID: 19472443
[TBL] [Abstract][Full Text] [Related]
36. A new mutation in PYGM causing McArdle disease in a Brazilian patient.
Gomes CP; da Silva AMS; Zanoteli E; Pesquero JB
Acta Neurol Belg; 2020 Jun; 120(3):705-707. PubMed ID: 31175620
[No Abstract] [Full Text] [Related]
37. A new rare mutation (691delCC/insAAA) in exon 17 of the PYGM gene causing McArdle disease.
Quintans B; Sanchez-Andrade A; Teijeira S; Fernandez-Hojas R; Rivas E; López MJ; Navarro C
Arch Neurol; 2004 Jul; 61(7):1108-10. PubMed ID: 15262743
[TBL] [Abstract][Full Text] [Related]
38. A novel PYGM mutation in a Korean patient with McArdle disease: the role of nonsense-mediated mRNA decay.
Sohn EH; Kim HS; Lee AY; Fukuda T; Sugie H; Kim DS
Neuromuscul Disord; 2008 Nov; 18(11):886-9. PubMed ID: 18667317
[TBL] [Abstract][Full Text] [Related]
39. PYGM mRNA expression in McArdle disease: Demographic, clinical, morphological and genetic features.
Carvalho AAS; Christofolini DM; Perez MM; Alves BCA; Rodart I; Figueiredo FWS; Turke KC; Feder D; Junior MCF; Nucci AM; Fonseca FLA
PLoS One; 2020; 15(7):e0236597. PubMed ID: 32735634
[TBL] [Abstract][Full Text] [Related]
40. Taking advantage of an old concept, "illegitimate transcription", for a proposed novel method of genetic diagnosis of McArdle disease.
Garcia-Consuegra I; Blázquez A; Rubio JC; Arenas J; Ballester-Lopez A; González-Quintana A; Andreu AL; Pinós T; Coll-Cantí J; Lucia A; Nogales-Gadea G; Martín MA
Genet Med; 2016 Nov; 18(11):1128-1135. PubMed ID: 26913921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
